(Q42206798)

18 October 2017

title

Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent (English)

1 reference

18 October 2017

1 reference

J J Curtis

1

1 reference

18 October 2017

R G Luke

series ordinal

2

1 reference

18 October 2017

P Jones

series ordinal

3

1 reference

18 October 2017

A G Diethelm

series ordinal

4

1 reference

18 October 2017

language of work or name

English

0 references

publication date

1 August 1988

1 reference

American Journal of Medicine

18 October 2017

published in

1 reference

18 October 2017

volume

85

1 reference

18 October 2017

issue

2

1 reference

18 October 2017

page(s)

134-138

1 reference

Hypertension after successful renal transplantation.

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Cyclosporine-associated chronic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Acute tubular necrosis and arterial hypertension in renal transplant patients treated with ciclosporin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Side effects of cyclosporin A treatment in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Side effects of systemic cyclosporine in patients not undergoing transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Cyclosporin in therapeutic doses increases renal allograft vascular resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Cyclosporine nephrotoxicity without major organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Side effects and safety of Sandimmun in long-term treatment of renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Plasma Volume in Men with Essential Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Suppressor and cytolytic cell function in multiple sclerosis. Effects of cyclosporine A and interleukin 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Posttransplant hypertension: Studies of cortical blood flow and the renal pressor system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Role of the Renin-Angiotensin System in Post-Transplantation Hypertension in Patients with Multiple Kidneys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Mechanisms of posttransplant hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Effect of cyclosporin on renin-angiotensin-aldosterone system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Effect of cyclosporine administration on renal hemodynamics in conscious rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

Suppression of plasma renin activity by cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980331-0

10.1016/S0002-9343(88)80331-0

7 January 2021

Identifiers

DOI

1 reference

18 October 2017

1 reference